Literature DB >> 6118479

Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

W Weimar, J Stibbe, A J van Seyen, A Billiau, P De Somer, D Collen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6118479     DOI： 10.1016/s0140-6736(81)91217-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis.

Authors:  N Baziuk; T Fang; G A Peyman; C M Gremillion
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

2.  Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease states.

Authors:  D Collen
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

3.  THROMBOLYSIS IN MYOCARDIAL INFARCTION.

Authors:  S D Karloopia
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.

Authors:  G de Gaetano; V Bertelé
Journal:  Agents Actions       Date:  1984-01

Review 5.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

Review 6.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

Review 7.  tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.

Authors:  Linda Fredriksson; Daniel A Lawrence; Robert L Medcalf
Journal:  Semin Thromb Hemost       Date:  2016-09-27       Impact factor: 4.180

8.  Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.

Authors:  D Collen; J M Stassen; M Verstraete
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

9.  Coronary thrombolysis with tissue-type plasminogen activator: prospective review.

Authors:  D Collen D
Journal:  Tex Heart Inst J       Date:  1984-12

Review 10.  Use of thrombolytic drugs in non-coronary disorders.

Authors:  M Verstraete
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.